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Are steroid injections  
effective for tenosynovitis  
of the hand?
z Evidence summary
Flexor tenosynovitis and de Quervain’s 
tenosynovitis are the 2 most common 
types of tenosynovitis of the hand. 
While the term “tenosynovitis” implies 
an inflammatory condition, pathoana-
tomically it is better described as a fric-
tion overuse injury, resulting in fibrosis 
  
Yes.	steroid	injections	are	an	effective	
first-line	therapy	for	flexor	tenosynovitis	of	
the	hand,	with	a	number	needed	to	treat	
[NNT]	of	2.3	for	injection	of	steroids	and	
lidocaine	(strength	of	recommendation	
[sor]:	B,	based	on	1	prospective	rcT	
and	2	low-quality	studies).	Injection	into	
the	tendon	sheath	may	not	be	critical	to	a	
successful	outcome	(sor:	B,	based	on		
1	prospective	uncontrolled	trial).
	 For	de	quervain’s	tenosynovitis,	
steroid	injections	without	splinting	are	
more	effective	than	injection	plus	splinting	
or	splinting	alone.	The	cure	rates	are	83%	
(steroid	alone),	61%	(steroid	plus	splinting),	
and	14%	(splinting	alone)	(sor:	B,	based	
on	a	systematic	review	of	descriptive	
noncontrolled	studies).	Injecting	into	the	
tendon	compartments	was	more	effective	
than	injecting	into	the	surrounding	soft	
tissues	(sor:	B,	based	on	1	prospective	
controlled	trial).
Steroids are helpful, especially  
for a quick return to function
I	often	see	flexor	and	de	quervain’s	
tenosynovitis	in	my	practice,	particularly	
among	patients	whose	occupations	require	
repetitive	hand	use.	Acute	treatment	
for	these	conditions	typically	consists	
of	immobilization	with	buddy	taping	or	
finger/thumb	spica	splinting.	For	those	
who	do	not	improve	in	4	weeks,	or	require	
a	quick	return	to	function,	I’ve	found	that	
corticosteroid	injection	using	a	25-	to	30-
gauge	needle	can	be	very	effective.	
	 De	quervain’s	tenosynovitis	must	
be	injected	into	the	sheath	between	the	
abductor	longus	and	extensor	pollicis	
brevis;	flexor	tenosynovitis	is	injected	in	the	
nodule.	I	typically	have	excellent	results,	with	
patients	returning	to	function	within	72	hours.	
Depigmentation	and	atrophy	can	occur	with	
injections,	especially	in	small-statured	or	
dark-pigmented	patients.	surgical	release	is	
rarely	required	for	either	condition.
	 Infectious	tenosynovitis	must	be	
recognized	early;	it	is	typically	due	to	
lacerations	or	puncture	wounds.	In	these	
cases,	I	immediately	refer	to	orthopedic	
surgery	for	further	treatment	and	evaluation.
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The exact  
location of  
a steroid injection 
for flexor  
tenosynovitis  
of the hand does 
not appear  
to be important 
fast track
1046 vol	56,	No	12	/	December	2007		ThE Journal of family PraCTiCE
C
l
in
iC
a
l
 I
N
q
u
Ir
Ie
s
of the surrounding tissue and subsequent 
narrowing of the synovium.1 
Flexor tenosynovitis:  
Steroid injections provided relief 
A prospective, double-blinded RCT2 
published by an orthopedic group in 
1995 compared 24 patients with pri-
mary flexor tenosynovitis. Patients were 
injected with either 1 cc of betametha-
sone (Celestone 6 mg) and 3 cc of 1% 
lidocaine, or 4 cc of 1% lidocaine alone. 
A successful outcome was defined as ab-
sence of triggering and pain, both sub-
jectively and on examination. Follow-
up examination was completed for all 
patients at 3 weeks and 4 months after 
injection.
The treatment group had success 
outcomes for 10 of 14 patients (71%) at 
3 weeks and 9 of 14 patients (64%) at 
4 months, compared with 2 of 10 (20%) 
at both 3 weeks and 4 months in the 
control group (NNT=2.3; P<.05 at 4 
months). No significant side effects were 
noted. It is unclear how the study blinded 
the white, thick consistency of betameth-
asone compared with the clear nature of 
lidocaine alone.
injection site may not matter. In an-
other prospective, uncontrolled trial, 107 
patients with flexor tenosynovitis were 
injected with 1 cc of betamethasone, 0.5 
cc of 1% lidocaine, and 0.5 cc of radio 
opaque dye.3 Some patients got their in-
jections in the tendon sheath at the A1 
pulley site, others got their injections in 
the subcutaneous tissue surrounding the 
pulley, and a third group got injections 
in both sites. Patients graded their relief 
subjectively as either good (total allevia-
tion of symptoms), fair (lasting improve-
ment), or poor (only transient improve-
ment or none at all). 
Those who received an intrasheath 
injection reported good results 47% of 
the time at 2 weeks follow-up, compared 
with 70% and 50% for patients in the 
subcutaneous and mixed groups, respec-
tively. There was no statistically significant 
difference between the groups, suggesting 
that the exact location of injection may 
not be important. 
de Quervain’s tenosynovitis:  
Steroids better than splinting
A pooled quantitative literature search 
concerning the treatment of de Quer-
vain’s tenosynovitis compared 7 studies 
(a total of 459 wrists) with identical diag-
nostic and success criteria.4 Average fol-
low-up was 9.6 months (range, 1 week to 
7 years). There were no control groups in 
the studies, and none of the studies were 
randomized. Of the 226 cases treated 
with steroid injection alone, 83% were 
cured, though 30 of these needed a sec-
ond injection. Sixty-one percent of those 
treated with injection and splint were 
cured, while 14% treated with splint 
alone reported cure. 
Steroids outperform splinting and 
nSaiDs. A retrospective study not includ-
ed in the above review compared steroid 
injection with splinting and nonsteroi-
dal anti-inflammatory drugs (NSAIDs).5 
Researchers stratified subjects into mini-
mal, mild, or moderate-to-severe, based 
on their severity of disease and limitation 
on their activities of daily living. Mean 
follow-up was 2.3 years. 
Of those cases treated with splinting 
and NSAIDs, 15 of 17 in the minimal 
group had resolution of symptoms, but 
only 4 of 20 in the mild group and 2 of 
8 in the moderate-to-severe group had 
symptoms resolve. The injection group 
obtained better results, with 100% of 
cases in the minimal and mild groups re-
solving and 76% of those in the more se-
vere group resolving completely, with an 
additional 7% reporting improvement. 
injection site appears to matter with 
de Quervain’s tenosynovitis. In 1 small, 
controlled, prospective, double-blinded 
study, the authors attempted to correlate 
clinical relief of de Quervain’s tenosyno-
vitis with accuracy of injection into the 
first dorsal compartment.6 The research-
ers enrolled 19 patients. The same hand 
surgeon injected 3 cc of 1% lidocaine, 
1 cc betamethasone, and 1 cc Omnip-
For de Quervain’s 
tenosynovitis,  
steroid injection 
into the tendon  
compartments 
was more effective 
than injection into 
the surrounding 
soft tissue  
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aque 300 dye into the abductor pollicis 
longus sheath and then attempted, with 
ulnar deviation of the needle, to fill the 
extensor pollicis brevis sheath. 
Patients were followed-up at 1 
month and 3 months postinjection. 
Success—defined as a negative Finkel-
stein’s test, absence of pain, and normal 
activities of daily living—was noted in 
11 of 19 patients at 3 months. In a ra-
diographic check, 4 of 5 of the patients 
with dye in both compartments were 
asymptomatic, while the 3 who had no 
dye in either compartment remained 
symptomatic. This suggests that the lo-
cation of injection may be important in 
de Quervain’s tenosynovitis. 
Recommendations from others
The Brigham and Women’s Hospital 
guidelines for treatment of de Quervain’s 
tenosynovitis state that corticosteroid in-
jections “may be very helpful,” and that 
they should be considered if symptoms 
persist beyond 6 weeks of conservative 
treatment.7 DeLee and Drez’s Orthope-
dic Sports Medicine text recommends 
corticosteroid injection for de Quervain’s 
tenosynovitis after 2 weeks of conserva-
tive treatment have failed.8 
UpToDate recommends steroid in-
jection for de Quervain’s tenosynovi-
tis if pain persists for more than 2 to 
6 weeks despite splinting, icing, and 
NSAID therapy.9 For flexor tenosynovi-
tis, UpToDate recommends local injec-
tion when symptoms persist for 4 to 6 
weeks despite splinting.10   n
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